Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 226–240 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3230 ELANE Gene Sequencing for Severe Congenital Neutropenia Type 1 (NGS) Test This test identifies pathogenic variants in the ELANE gene associated with Severe Congenital Neutropenia Type 1 (SCN1).	Whole blood (EDTA), extracted DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ELANE gene sequence", "Pathogenic variants in ELANE gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab if patient is on G-CSF"] Indications ["Suspected Severe Congenital Neutropenia Type 1 (SCN1)", "Family history of SCN1", "Need for genotype-phenotype correlation", "Planning G-CSF therapy", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 93685-6 ICD-10: D70.0, Z15.89, D70.8 Clinical summary This test identifies pathogenic variants in the ELANE gene associated with Severe Congenital Neutropenia Type 1 (SCN1).
TEST-1630 Endocrine Cancer Gene Panel Test This test evaluates for inherited mutations in genes associated with hereditary endocrine tumour syndromes using Next-Generation Sequencing (NGS).	Peripheral whole blood (EDTA tube)	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["≥30 genes associated with hereditary endocrine tumour syndromes", "Mutations in genes like MEN1, MEN2, RET, VHL"] Parameters [] Preparation ["No fasting required.", "Inform the phlebotomist of all medications and supplements."] Indications ["Individuals with a personal or family history suggestive of hereditary endocrine tumour syndromes.", "Screening for high-risk individuals based on family history.", "Diagnostic confirmation in suspected cases."] Measurement technique Confirm with laboratory Codes LOINC: 55233-5 ICD-10: Z15.04 Clinical summary This test evaluates for inherited mutations in genes associated with hereditary endocrine tumour syndromes using Next-Generation Sequencing (NGS).
TEST-137 Environmental RNA Extraction Service Test This service provides high-purity total RNA extracted from environmental or biological samples.	Environmental soil, whole blood (EDTA), previously extracted DNA	1 week	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Total RNA integrity", "RNA purity (A260/A280 ratio)", "RNA concentration"] Parameters [{"name": "RNA Purity (A260/A280)", "reference_range": "≥2.0"}, {"name": "RNA Integrity Number (RIN)", "reference_range": "≥7"}] Preparation [] Indications ["Research requiring high-quality RNA", "Clinical diagnostics involving gene expression", "Viral load quantification", "Environmental monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 64038-6 ICD-10: Z15.01, Z13.7, Z01.89 Clinical summary This service provides high-purity total RNA extracted from environmental or biological samples.
TEST-1618 Eosinophilic Leukemia FISH Panel Test This diagnostic test evaluates for specific genetic rearrangements associated with eosinophilic myeloid/lymphoid neoplasms using Fluorescence In-Situ Hybridization (FISH).	Bone Marrow Aspirate / Peripheral Blood	3–4 working days	2,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cryptic rearrangements in PDGFRA", "Cryptic rearrangements in PDGFRB", "Cryptic rearrangements in FGFR1", "Cryptic rearrangements in PCM1-JAK2"] Parameters [] Preparation ["No specific patient preparation required", "Requires a valid doctor's prescription (exceptions apply)"] Indications ["Diagnosis of eosinophilic myeloid/lymphoid neoplasms", "Guiding targeted therapy with tyrosine kinase inhibitors"] Measurement technique Confirm with laboratory Codes LOINC: 57712-2 ICD-10: C94.7 Clinical summary This diagnostic test evaluates for specific genetic rearrangements associated with eosinophilic myeloid/lymphoid neoplasms using Fluorescence In-Situ Hybridization (FISH).
TEST-3165 EPB42 Gene Spherocytosis Type 5 Genetic Test This genetic test identifies mutations in the EPB42 gene associated with Hereditary Spherocytosis type 5.	Whole Blood (Peripheral) – EDTA Tube (3–5 mL)	12–15 Business Days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EPB42 gene mutations", "Red blood cell membrane stability defects"] Parameters [] Preparation ["Pre-test genetic counselling session required.", "Completed pedigree chart required.", "Signed informed consent required."] Indications ["Diagnosis of Hereditary Spherocytosis type 5", "Family risk assessment", "Informed clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 33907-5 ICD-10: D58.0 Clinical summary This genetic test identifies mutations in the EPB42 gene associated with Hereditary Spherocytosis type 5.
TEST-1625 Epidermal Growth Factor Receptor (EGFR) Mutation Analysis (Exons 18–21) Test This test detects specific mutations in the EGFR gene (exons 18-21) relevant to targeted cancer therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block, Biopsy Slides, or Surgical Pathology Cuts	3–4 Working Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR gene mutations (SNVs, indels)", "Exon 18, 19, 20, 21 variants"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of NSCLC", "Guidance for TKI therapy selection", "Prognostic information"] Measurement technique Confirm with laboratory Codes LOINC: 5827-7 ICD-10: C34.9, Z85.1 Clinical summary This test detects specific mutations in the EGFR gene (exons 18-21) relevant to targeted cancer therapy.
TEST-1050 Episodic Ataxia Type 1 Hotspot Test This genetic test identifies specific mutations in the KCNA1 gene associated with Episodic Ataxia Type 1.	EDTA whole blood (peripheral)	5 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the KCNA1 gene"] Parameters [] Preparation ["No fasting required", "No medication adjustments necessary", "Complete Genomics Clinical Information Form (Form 20)"] Indications ["Suspected Episodic Ataxia Type 1", "Family history of Episodic Ataxia Type 1"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.8 Clinical summary This genetic test identifies specific mutations in the KCNA1 gene associated with Episodic Ataxia Type 1.
TEST-5315 EPM2A Gene Lafora Disease Genetic Test This test identifies pathogenic variants in the EPM2A gene associated with Lafora disease (progressive myoclonic epilepsy type 2).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EPM2A gene", "Deletions/Duplications in the EPM2A gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Referral from a neurologist, clinical geneticist, or paediatric neurologist required"] Indications ["Suspected Lafora disease", "Progressive myoclonic epilepsy type 2"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the EPM2A gene associated with Lafora disease (progressive myoclonic epilepsy type 2).
TEST-1057 Epstein-Barr Virus (EBV) Qualitative PCR Test This test detects the presence of Epstein-Barr Virus (EBV) DNA in blood or CSF.	Whole blood (EDTA) or cerebrospinal fluid (CSF)	24 to 48 hours from sample receipt	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of EBV DNA", "Viral load (semi-quantitative via Ct values)"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Do not stop taking any prescribed medications unless directed by your physician."] Indications ["Suspected acute primary EBV infection (infectious mononucleosis)", "Monitoring viral reactivation in immunocompromised patients", "Distinguishing primary infection from past exposure", "Evaluating neurological complications of EBV"] Measurement technique Confirm with laboratory Codes LOINC: ['30010-1', '88592-2'] ICD-10: ['B27.90', 'B27.0'] Clinical summary This test detects the presence of Epstein-Barr Virus (EBV) DNA in blood or CSF.
TEST-8 Epstein-Barr Virus Early RNA (EBER-ISH) In Situ Hybridization Test This test detects the presence and location of Epstein-Barr Virus (EBV) RNA within tissue samples.	Tissue biopsy (formalin-fixed, paraffin-embedded)	10–12 days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EBV-encoded RNA", "Viral RNA localization in tissue"] Parameters [] Preparation ["No special fasting or medication adjustment needed"] Indications ["Classification of EBV-associated malignancies", "Guiding targeted therapies for EBV-driven cancers"] Measurement technique Confirm with laboratory Codes LOINC: 16151-9 ICD-10: C83.7, C83.3, D47.Z9 Clinical summary This test detects the presence and location of Epstein-Barr Virus (EBV) RNA within tissue samples.
TEST-119 Eukaryotic mRNA Sequencing & Reference-Based Analysis (Low Input) Test This test evaluates the expression levels of messenger RNA (mRNA) across the entire transcriptome from a small sample.	Whole blood (PAXgene Blood RNA tube) or tissue (RNAlater)	8 weeks (expedited reporting available)	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene expression levels", "Transcriptome profiling", "Differential gene expression"] Parameters [] Preparation ["No fasting or dietary restrictions required", "Continue all prescribed medications unless advised otherwise by your doctor", "Ensure sample collection uses RNase-free technique and appropriate preservative (PAXgene/RNAlater)"] Indications ["Oncogenomic profiling", "Rheumatic signatures", "Biomarker discovery", "Analysis of limited sample material (e.g., fine-needle aspirates, rare cell populations, archived samples)"] Measurement technique Confirm with laboratory Codes LOINC: 73487-2 ICD-10: Z12.9 Clinical summary This test evaluates the expression levels of messenger RNA (mRNA) across the entire transcriptome from a small sample.
TEST-111 Eukaryotic mRNA Sequencing & De Novo Analysis Test This test evaluates the entire transcriptome using de novo assembly to identify novel transcripts, gene fusions, and expression patterns.	Peripheral Whole Blood (PAXgene Blood RNA Tube)	8 weeks	5,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Transcriptome profile", "Novel transcripts", "Gene fusions", "Expression patterns"] Parameters [] Preparation ["No fasting or special diet required", "Maintain normal hydration", "Inform phlebotomist of blood-thinning medications"] Indications ["Cancer research", "Rare disease investigation", "Non-model organism studies"] Measurement technique Confirm with laboratory Codes LOINC: 91576-5 ICD-10: Z13.89 Clinical summary This test evaluates the entire transcriptome using de novo assembly to identify novel transcripts, gene fusions, and expression patterns.
TEST-122 Eukaryotic mRNA Sequencing and Reference-Based Analysis Test This test evaluates the expression levels of all coding transcripts within a sample.	Whole blood (PAXgene tube), fresh tissue, or cells	8 weeks	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene expression levels", "Whole transcriptome coverage"] Parameters [] Preparation ["No fasting required"] Indications ["Oncology", "Rheumatology", "Advanced biomedical research"] Measurement technique Confirm with laboratory Codes LOINC: 81292-5 ICD-10: Z01.8 Clinical summary This test evaluates the expression levels of all coding transcripts within a sample.
TEST-64 Eukaryotic mRNA Sequencing De Novo Data Analysis (RNA‑seq) Test This test analyzes the complete set of mRNA transcripts in a sample without a reference genome, identifying novel genetic elements.	Whole blood – PAXgene Blood RNA Tube	4 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Novel transcripts", "Splice variants", "Fusion genes", "Gene expression levels (relative)"] Parameters [{"name": "Read Depth", "reference_range": null}, {"name": "Assembly Size", "reference_range": null}, {"name": "Number of Novel Transcripts", "reference_range": null}] Preparation ["No fasting required", "No medication changes needed", "Inform phlebotomist if taking anticoagulants"] Indications ["Diagnosis of rare diseases with unknown etiology", "Cancer subtyping and identification of novel fusion genes", "Biomarker discovery in research settings", "Cases where reference-based RNA-seq is inconclusive"] Measurement technique Confirm with laboratory Codes LOINC: 93005-4 ICD-10: Z01.8 Clinical summary This test analyzes the complete set of mRNA transcripts in a sample without a reference genome, identifying novel genetic elements.
TEST-63 Eukaryotic mRNA Sequencing Reference-Based Data Analysis Test This test evaluates the expression levels of messenger RNA (mRNA) from a patient's cells, providing a comprehensive view of gene activity.	Peripheral Whole Blood (PAXgene RNA Tube)	4 Weeks	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene expression levels", "mRNA profiles", "Transcriptome activity"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of all medications", "Avoid strenuous exercise 12 hours prior", "Reschedule if unwell"] Indications ["Precision oncology", "Rheumatology", "Research-grade insight", "Identifying disease mechanisms"] Measurement technique Confirm with laboratory Codes LOINC: 85705-3 ICD-10: Z01.81 Clinical summary This test evaluates the expression levels of messenger RNA (mRNA) from a patient's cells, providing a comprehensive view of gene activity.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories